首页> 外国专利> METHOD FOR STRATIFYING THE RISK OF BK VIRUS NEPHROPATHY AFTER A KIDNEY TRANSPLANT

METHOD FOR STRATIFYING THE RISK OF BK VIRUS NEPHROPATHY AFTER A KIDNEY TRANSPLANT

机译:在肾移植后分层BK病毒肾病风险的方法

摘要

The present application describes and claims a novel method for identifying and stratifying the risk of developing a BK virus nephropathy (“Nx BK-v” below) in patients having undergone a kidney transplant. This method uses an index combining at least three bio-markers: i) the intensity of the anti-BK-v memory T lymphocyte response (memory T lymphocytes which are specific to v, hereinafter “LTm anti-BK-v”), ii) the number of occurrences of incompatibility in the HLA alleles of class I and class II between the donor and the recipient of the graft, taking into account iii) the viral charge of the BK-v virus in the whole blood of the patient. The present method allows a very precise evaluation of the risk of developing an Nx BK-v during the months following the test with the aim of optimising the immuno-suppressive treatment in order to better preserve the transplanted kidney.
机译:本申请描述并要求一种新的方法,用于鉴定和分层在经过肾移植的患者中鉴定和分层开发BK病毒肾病的风险(“NX BK-V”)。 该方法使用索引组合至少三个生物标记:i)抗BK-V内存T淋巴细胞反应的强度(目前v的内存T淋巴细胞,下文中称为“LTM抗BK-V”),II )在I类和施主和移植物的接受者之间的HLA等位基因中不相容的次数,考虑III)在患者的全血中BK-V病毒的病毒电荷。 本方法允许非常精确评估在测试后几个月内开发NX BK-V的风险,其目的是优化免疫抑制治疗,以便更好地保留移植的肾脏。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号